GROWTH Programs are designed for the following users:
DOC Search
Designed for:
Medical Professional Societies
Clinical Researchers
Academic Organizations
Healthcare Providers
GROWTH Evidence
Designed for:
Medical Professional Societies
Healthcare Providers
Evidence-based Practice Centers
Guideline Panels
GROWTH Research
Designed for:
Academic Research Centers
Health and Hospital Systems
Evidence-based Practice Centers
Practice-based Research Networks
NEWS : Doctor Evidence CEO Awarded Two Honorary Fellowships Robert Battista was recently selected for fellowship in the Royal College of Physicians of Edinburgh and the Royal Society for Public Health.
SANTA MONICA, Calif., Nov. 27, 2018 /PRNewswire/ -- Doctor Evidence announces the awarding of two honorary fellowships to Robert Battista, the CEO and co-founder, in recognition for his innovative work in healthcare. The Royal College of Physicians of Edinburgh and the Royal Society for Public Health have conferred these honors on Mr. Battista following nominations from and voting by their respective memberships. He was elected to fellowship in recognition of his substantive contributions to the medical community and career commitment to the improvement of healthcare, particularly uniting otherwise disparate communities in the ecosystem to collaborate for better patient wellbeing.
NEWS : Doctor Evidence Conducted Systematic Evidence Review for Leading Cardiology Societies for Bradycardia Guideline Evidence Review and Analyses
SANTA MONICA, Calif., Nov. 6, 2018 /PRNewswire/ -- Today, the American College of Cardiology (ACC), American Heart Association (AHA), and Heart Rhythm Society (HRS) published guidelines on the diagnosis and treatment of bradycardia, an abnormally slow heart rate, along with the supporting systematic review. The 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay were simultaneously published in Circulation, the Journal of the American College of Cardiology (JACC), and HeartRhythm. An Executive Summary was also published in all three journals: Circulation, JACC, and HeartRhythm.
NEWS : Connecting Published Data To Real World Evidence: What's The DIF (Data Impact Factor)
SANTA MONICA, Calif., Nov. 5, 2018 /PRNewswire/ -- Doctor Evidence has launched DIF—the Data Impact Factor—technology for identifying data cohorts, across time and various reported data sets. As technology progresses, it has become possible to move from past paradigms, like the Journal Impact Factor, which is an index of the relative influence of leading journals. Today's innovative technologies can assign actual weights, prominence, and influence factors to individual data cohorts across all research or within a selected topic area. DIF embraces the increased capabilities for micro-tagging of clinical trial research and subsequent representations of that data.
NEWS : The American Society Of Hematology To Make Its Meeting Abstracts Available In Leading Artificial Intelligence Technology Platform
WASHINGTON, Oct. 26, 2018 /PRNewswire/ -- The American Society of Hematology (ASH), has entered into an agreement with Doctor Evidence (DRE) to host ASH annual meeting abstracts in DRE's innovative DOC Search artificial intelligence technology platform. ASH is the world's largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.
NEWS : American Thoracic Society publishes guideline on malignant pleural effusions; Doctor Evidence collaborated on the underlying meta-analysis
New Guideline Recommends Minimally Invasive Ways of Treating Malignant Pleural Effusions
Oct. 1, 2018─A new guideline to help clinicians manage malignant pleural effusions (MPEs) has been developed by the American Thoracic Society, the Society of Thoracic Surgeons and the Society of Thoracic Radiology. The clinical practice guideline is published online in the Oct. 1 American Journal of Respiratory and Critical Care Medicine.
Stay up to date with the evolving science of evidence-based medicine (EBM) with GROWTH Commentaries, a series of monthly open-access essays written by well-known experts in the field. GROWTH Commentaries represent high-quality research and new developments in the practice of EBM and provide insights from thought-leaders in the design and methods of informed clinical decisions based on solid data and trusted processes.
Can AI Help Rescue the Healthcare Economic Crisis?
By Eric Topol, MDExecutive Vice President, Scripps ResearchFounder and Director, Scripps Research Translational InstituteProfessor, Molecular Medicine Introduction If we are…
Read MoreThinking Differently About Evidence Development In the Age of Digital Health
By Davis Walp, MBA Founder / CEO Health Analytics Strategies LLC Healthcare struggles with a definitional problem – where and…
Read MoreToward the Transformation of Healthcare Delivery: Digital Health Platforms
Post a comment By Blackford Middleton, MD, MPH, MScChief Informatics and Innovation OfficerApervita, Inc Introduction Modern healthcare delivery is in…
Read MoreExperimental trial design and routine data: A promising approach for real-world evidence
By Heiner C. Bucher, MD, MPHDirector, Basel Institute for Clinical Epidemiology & BiostatisticsUniversity Hospital & University of BaselBasel, Switzerland Introduction…
Read MoreDigital health: The hardest tech problem has been solved before
By Tom Sullivan Editor-in-Chief of Healthcare IT News Director of Content Development, HIMSS Media Introduction I went into the Healthcare…
Read MoreContinuing the Exploration of Guideline Dissemination Through Social Media
By Thomas S. D. Getchius Director of Guideline Strategy and OperationsAmerican Heart Association/American College of CardiologyFellow, New York Academy of…
Read More15 Years Past, Present, & Future: Being Digital
By Robert Battista, MBA, FRSPH, FRCP Edin. Chief Executive Officer, Doctor Evidence Looking Back There are not many things that you…
Read MoreEBM and Public Policy: Obstacles and Opportunities in Congress
By Tom AllenFormer member of the United States House of Representatives (D-ME) Background I represented Maine’s first Congressional District in…
Read MoreUnderstanding How Health Systems View the Pros and Cons of Different Evidence Types
By C. Michael White, PharmD, Professor & Head of Pharmacy Practice, University of Connecticut School of Pharmacy, and Co-Director, University…
Read MoreNew Opportunities for Evidence-Based Policymaking in Health Care
By Sherry Glied, MS, PhD Dean, NYU Wagner Graduate School of Public Service Member, Commission on Evidence-Based Policymaking Introduction Last…
Read MoreDon't know where to start?...
Our team will be happy to help you.
Can AI Help Rescue the Healthcare Economic Crisis?
By Eric Topol, MDExecutive Vice President, Scripps ResearchFounder and Director, Scripps Research Translational InstituteProfessor, Molecular Medicine Introduction If we are…
Read More